
Talphera, Inc., formerly AcelRx Pharmaceuticals, Inc., is a specialty pharmaceutical company. The Company is focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Niyad is focused... Talphera, Inc., formerly AcelRx Pharmaceuticals, Inc., is a specialty pharmaceutical company. The Company is focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Niyad is focused on developing regional anticoagulants for injection into the extracorporeal circuit, such as the dialysis circuit during continuous renal replacement therapy (CRRT) for acute kidney injury (AKI) patients in the hospital, and for chronic kidney disease patients undergoing intermittent hemodialysis (IHD) in dialysis centers. LTX-608 is nafamostat formulation for direct intravenous (IV) infusion that shall be investigated and developed as a potential anti-viral for the treatment of COVID, acute respiratory distress syndrome (ARDS) disseminated intravascular coagulation (DIC), and acute pancreatitis. The Company is also engaged in developing two pre-filled syringes, namely Fedsyra and PFS-02. 詳細を表示
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.0299 | 4.90163934426 | 0.61 | 0.68 | 0.6021 | 57871 | 0.64405886 | CS |
4 | -0.0111 | -1.70506912442 | 0.651 | 0.7782 | 0.54 | 70138 | 0.6567133 | CS |
12 | -0.0826 | -11.4325259516 | 0.7225 | 0.8 | 0.501 | 98322 | 0.63031134 | CS |
26 | -0.2901 | -31.1935483871 | 0.93 | 1.19 | 0.501 | 96177 | 0.80153176 | CS |
52 | -0.6901 | -51.8872180451 | 1.33 | 1.5 | 0.501 | 80931 | 0.91431565 | CS |
156 | -0.2201 | -25.5930232558 | 0.86 | 1.61 | 0.501 | 90891 | 0.93982838 | CS |
260 | -0.2201 | -25.5930232558 | 0.86 | 1.61 | 0.501 | 90891 | 0.93982838 | CS |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約